Neoadjuvant PAXG Outperforms mFOLFIRINOX in Resectable and Borderline Resectable PDAC Read More » June 4, 2025
New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy Read More » February 20, 2025
High-dose IV vitamin C plus chemotherapy doubles survival in advanced pancreatic cancer Read More » November 25, 2024
FDA Awards Orphan Drug Designation to Avutometinib Plus Defactinib in Pancreatic Cancer Read More » August 7, 2024
